The impact of empagliflozin on cardiac physiology and fibrosis early after myocardial infarction in non-diabetic rats
出版年份 2021 全文链接
标题
The impact of empagliflozin on cardiac physiology and fibrosis early after myocardial infarction in non-diabetic rats
作者
关键词
-
出版物
Cardiovascular Diabetology
Volume 20, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2021-07-03
DOI
10.1186/s12933-021-01322-6
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Response by Lee et al to Letter Regarding Article, “Cardiovascular Risk of Isolated Systolic or Diastolic Hypertension in Young Adults”
- (2021) Hokyou Lee et al. CIRCULATION
- Pathological cardiac remodeling seen by the eyes of proteomics
- (2021) Diana Paola Gómez-Mendoza et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- Load-independent effects of empagliflozin contribute to improved cardiac function in experimental heart failure with reduced ejection fraction
- (2020) Kim A. Connelly et al. Cardiovascular Diabetology
- Mechanisms of Cardiorenal Effects of Sodium-Glucose Cotransporter 2 Inhibitors
- (2020) Thomas A. Zelniker et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Randomized Trial of Empagliflozin in Nondiabetic Patients With Heart Failure and Reduced Ejection Fraction
- (2020) Carlos G. Santos-Gallego et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Empagliflozin Ameliorates Diastolic Dysfunction and Left Ventricular Fibrosis/Stiffness in Nondiabetic Heart Failure
- (2020) Carlos G. Santos-Gallego et al. JACC-Cardiovascular Imaging
- Ischemic heart failure as a complication of incident acute myocardial infarction: Timing and time trends: A national analysis including 78,814 Danish patients during 2000–2009
- (2019) Gerhard Sulo et al. SCANDINAVIAN JOURNAL OF PUBLIC HEALTH
- Metabolism of the failing heart and the impact of SGLT2 inhibitors
- (2019) Alvaro Garcia-Ropero et al. Expert Opinion on Drug Metabolism & Toxicology
- The sodium–glucose co-transporter 2 inhibitor empagliflozin attenuates cardiac fibrosis and improves ventricular hemodynamics in hypertensive heart failure rats
- (2019) Hsiang-Chun Lee et al. Cardiovascular Diabetology
- Sodium–glucose co‐transporter 2 inhibition with empagliflozin improves cardiac function in non‐diabetic rats with left ventricular dysfunction after myocardial infarction
- (2019) Salva R. Yurista et al. EUROPEAN JOURNAL OF HEART FAILURE
- Empagliflozin Ameliorates Adverse Left Ventricular Remodeling in Nondiabetic Heart Failure by Enhancing Myocardial Energetics
- (2019) Carlos G. Santos-Gallego et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Evaluation of the effect of sodium–glucose co‐transporter 2 inhibition with empagliflozin on morbidity and mortality of patients with chronic heart failure and a reduced ejection fraction: rationale for and design of the EMPEROR‐Reduced trial
- (2019) Milton Packer et al. EUROPEAN JOURNAL OF HEART FAILURE
- Direct effects of empagliflozin on extracellular matrix remodeling in human cardiac myofibroblasts: Novel translational clues to EMPA-REG OUTCOME
- (2019) Sean Kang et al. CANADIAN JOURNAL OF CARDIOLOGY
- Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
- (2019) John J.V. McMurray et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of Empagliflozin on Cardiac Function, Adiposity, and Diffuse Fibrosis in Patients with Type 2 Diabetes Mellitus
- (2019) Jung-Chi Hsu et al. Scientific Reports
- Dapagliflozin Attenuates Na+/H+ Exchanger-1 in Cardiofibroblasts via AMPK Activation
- (2018) Yumei Ye et al. CARDIOVASCULAR DRUGS AND THERAPY
- Dapagliflozin, a selective SGLT2 Inhibitor, attenuated cardiac fibrosis by regulating the macrophage polarization via STAT3 signaling in infarcted rat hearts
- (2017) Tsung-Ming Lee et al. FREE RADICAL BIOLOGY AND MEDICINE
- High-Intensity Training Improves Global and Segmental Strains in Severe Congestive Heart Failure
- (2017) Yair Blumberg et al. JOURNAL OF CARDIAC FAILURE
- Fibroblast-specific TGF-β–Smad2/3 signaling underlies cardiac fibrosis
- (2017) Hadi Khalil et al. JOURNAL OF CLINICAL INVESTIGATION
- Use of SGLT-2 inhibitors in the treatment of type 2 diabetes mellitus
- (2017) Leyna Leite Santos et al. Revista da Associacao Medica Brasileira
- Effects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure
- (2017) Milton Packer et al. JAMA Cardiology
- Empagliflozin decreases myocardial cytoplasmic Na+ through inhibition of the cardiac Na+/H+ exchanger in rats and rabbits
- (2016) Antonius Baartscheer et al. DIABETOLOGIA
- Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
- (2015) Bernard Zinman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Myofibroblasts in the Infarct Area: Concepts and Challenges
- (2012) Evangelos P. Daskalopoulos et al. MICROSCOPY AND MICROANALYSIS
- Left ventricular remodeling in the post-infarction heart: a review of cellular, molecular mechanisms, and therapeutic modalities
- (2010) Jason J. Gajarsa et al. HEART FAILURE REVIEWS
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started